Condition
Chronic Hep B
Total Trials
5
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Unknown2
Recruiting2
Active Not Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06635694Active Not Recruiting
naVIGation Invitations Liver surveillANce upTake
NCT06671093Phase 1RecruitingPrimary
Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
NCT07137247Recruiting
Immune Dynamics in the Natural History of Chronic HBV Infection
NCT04904900UnknownPrimary
Prospective Evaluation of a Fast-track Treatment Pathway for Patients With Chronic Hepatitis B Under Primary Care
NCT04568265Phase 2Unknown
A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B
Showing all 5 trials